
Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.12439/2831
Title: | Right Posterior Descending Artery Versus Left Posterior Descending Artery Percutaneous Coronary Intervention: Is There a Difference in Outcome?. |
Northern Health Authors: | Muhtasim Rahman Zahin;William van Gaal |
Northern Health first author: | Muhtasim Rahman Zahin |
Northern Health affiliation: | (Rahman Zahin, van Gaal) Northern Health, Melbourne, VIC, Australia |
Authors: | Rahman Zahin M.;Batchelor R.;Dinh D.;Brennan A.;van Gaal W.;Koshy A.;Biswas S.;Norman S.;Moran T.;Goh S.;Brooks M.;Stub D.;Reid C.;Lefkovits J. |
Citation: | Heart Lung and Circulation. Conference: 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand. Perth Convention and Exhibition Centre, Perth Australia. 33(Supplement 4) (pp S570), 2024. Date of Publication: August 2024. |
Issue Date: | 1-Aug-2024 |
Abstract: | Background: Coronary artery dominance has previously been described as a significant predictor of risk when undertaking percutaneous coronary intervention (PCI). PCI for left posterior descending artery (L-PDA) lesions involves wiring the left main coronary artery and more challenging angiographic projection of the circumflex-PDA. This may portend a higher risk as compared to posterior descending artery (R-PDA) PCI. We sought to compare characteristics and outcomes of R-PDA versus L-PDA PCI. Method(s): The Victorian Cardiac Outcomes Registry is a state-wide quality registry with all PCI capable centres in Victoria contributing. We undertook retrospective analysis of patients undergoing PCI for L-PDA and R-PDA lesions between 2013 and 2022. Result(s): 2,880 patients were included over the 10-year study period, 2,282 (79.2%) undergoing R-PDA PCI and 598 (20.8%) undergoing L-PDA PCI. Patient characteristics between groups were of similar age (66.3 years in both groups), gender (17.9% vs 14.5%; p=0.06) and had comparable rates of comorbidities such as diabetes (25.8% vs 24.9%; p=0.66). Femoral approach PCI was more common in the R-PDA group (35.6% vs 29.1%; p=0.003). There was no significant difference between groups with respect to 30-day mortality (1.1% vs 0.5%; p=0.21). 30-day MACE was also comparable (2.2% both groups; p=0.93). Conclusion(s): In contrast to earlier series, our data from a large contemporary cohort did not find any association between coronary dominance and outcomes when intervening upon the PDA.Copyright � 2024 |
URI: | https://hdl.handle.net/20.500.12439/2831 |
DOI: | https://dx.doi.org/10.1016/j.hlc.2024.06.969 |
Type: | Conference abstract |
Keywords: | diabetes mellitus |
Study/Trial: | Observational study (cohort, case-control, cross sectional, or survey) |
Access Rights: | Free article |
Place of publication: | Netherlands |
Conference Name: | 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand |
Conference Location: | Perth Convention and Exhibition Centre, Perth, Australia |
Appears in Collections: | Conference papers, presentations, and posters |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.